Cell senescence induced by toxic interaction between -synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease
Here are some key takeaways from the available human data: Clinical Trial Data : Human trials such as SUSTAIN-6 and LEADER have not demonstrated an increase in thyroid cancer diagnoses among patients using GLP-1 medications
Light steaming or brief cooking may enhance bioavailability of these compounds compared to raw consumption, though both forms provide benefits
Primary endpoint: composite of cardiovascular death, myocardial infarction, or ischemic stroke (94), composite of death from cardiovascular causes, non-fatal myocardial infarction, or non-fatal stroke (95), composite of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for unstable angina (96), or time to first occurrence of the composite of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke (97), respectively
It is prescribed off label by peptide clinics for healthy adults seeking wellness benefits
